Recent Insider Transactions - Spyre Therapeutics (NASDAQ: SYRE)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ SYRE Spyre Therapeutics

Fairmount Funds Management LLC / director

05/29/2025

Buy

$15.55

25,000

$389K

25,000

NASDAQ SYRE Spyre Therapeutics

Stelzer Laurie / director

05/29/2025

Buy

$15.55

25,000

$389K

25,000

NASDAQ SYRE Spyre Therapeutics

Milligan Sandra / director

05/29/2025

Buy

$15.55

25,000

$389K

25,000

NASDAQ SYRE Spyre Therapeutics

McKenna Mark C. / director

05/29/2025

Buy

$15.55

25,000

$389K

25,000

NASDAQ SYRE Spyre Therapeutics

HENDERSON MICHAEL THOMAS / director

05/29/2025

Buy

$15.55

25,000

$389K

25,000

NASDAQ SYRE Spyre Therapeutics

Albers Jeffrey W. / director

05/29/2025

Buy

$15.55

25,000

$389K

25,000